Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-08-21

Clinical Trial Update: Reducing Suicidal Ideation Through Treatment of Nightmares-Post Traumatic Stress Disorder (PTSD) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating treatment of nightmares in PTSD and its effect on suicidal ideation has completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Augusta University | Conditions: Post Traumatic Stress Disorder, Suicidal Ideation | Phase 4 | Status: COMPLETED | Results posted: 2018-08-21